Pages that link to "Q71852018"
Jump to navigation
Jump to search
The following pages link to Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks (Q71852018):
Displaying 30 items.
- The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs (Q28345449) (← links)
- Neurovascular contributions to migraine: Moving beyond vasodilation (Q28392631) (← links)
- Endosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteries (Q28577195) (← links)
- Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy (Q33709238) (← links)
- The pharmacology of headache (Q33952000) (← links)
- One Hundred Years of Migraine Research: Major Clinical and Scientific Observations From 1910 to 2010 (Q34180539) (← links)
- MRTF-A steers an epigenetic complex to activate endothelin-induced pro-inflammatory transcription in vascular smooth muscle cells (Q34249545) (← links)
- Modelling headache and migraine and its pharmacological manipulation (Q34407137) (← links)
- Targeting TRP channels for novel migraine therapeutics (Q34555756) (← links)
- 5-HT1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis (Q34649017) (← links)
- Almotriptan, a new anti-migraine agent: a review. (Q34917964) (← links)
- Origin of pain in migraine: evidence for peripheral sensitisation (Q34987743) (← links)
- A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation (Q35693015) (← links)
- Clinical pharmacology of bosentan, a dual endothelin receptor antagonist (Q35965785) (← links)
- Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms (Q36261133) (← links)
- Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches (Q36360319) (← links)
- Effects of the 5-HT1 receptor agonists sumatriptan and CP 93,129 on dural arterial flow in the rat (Q36881119) (← links)
- Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications. (Q36912182) (← links)
- Current and prospective pharmacological targets in relation to antimigraine action (Q37216396) (← links)
- CGRP and its receptors provide new insights into migraine pathophysiology (Q37785745) (← links)
- Animal migraine models for drug development: status and future perspectives (Q38162801) (← links)
- Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation (Q42116885) (← links)
- Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation (Q47734282) (← links)
- The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist (Q51396268) (← links)
- Episodic Migraine With and Without Aura: Key Differences and Implications for Pathophysiology, Management, and Assessing Risks (Q57021554) (← links)
- Vascular Contributions to Migraine: Time to Revisit? (Q58801458) (← links)
- BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential (Q77164374) (← links)
- A practical guide to the management and prevention of migraine (Q77601616) (← links)
- Migraine (Q79890177) (← links)
- The Role of Endothelin in the Pathophysiology of Migraine-a Systematic Review (Q88105921) (← links)